| James Katrivesis, MD | |
|
3277 E Louise Dr Ste 100, Meridian, ID 83642-9360 | |
| (208) 706-7086 | |
| Not Available |
| Full Name | James Katrivesis |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 13 Years |
| Location | 3277 E Louise Dr Ste 100, Meridian, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851687008 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| St Luke's Wood River Medical Center | Ketchum, ID | Hospital |
| St Luke's Elmore Medical Center | Mountain home, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uc Regents | 3274446182 | 70 |
| Boise Radiology Group Pllc | 9638153257 | 53 |
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
Researchers from the University of Chicago Medicine have received a five-year, $1.8 million grant, from the U.S. Department of Health and Human Services Office of Minority Health to develop a program that could help improve diabetes care for low-income racial and ethnic minority patients.
Although the overall rate of admissions to substance abuse treatment in the U.S. remained stable between 1998 and 2008, at about 770 admissions for every 100,000 persons in the population, a new study shows striking changes and variations in admission rates by region. For example, the rate of admissions for alcohol as the primary drug has declined by 15 percent nationally. However admission rates for alcohol in West North Central states (Ark., Iowa, Kan., Minn., Mo., N.D., Neb. and S.D.) remained the same.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.
A recent study discusses the findings of a study on patients with hematologic cancers who received convalescent plasma therapy following their diagnosis of COVID-19.
Current efforts to prevent prescription drug misuse among young adults need to consider peers - but not peer pressure - according to a Purdue University study.
› Verified 9 days ago
| Entity Name | Uc Regents |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346298528 PECOS PAC ID: 3274446182 Enrollment ID: O20031106000833 |
News Archive
Researchers from the University of Chicago Medicine have received a five-year, $1.8 million grant, from the U.S. Department of Health and Human Services Office of Minority Health to develop a program that could help improve diabetes care for low-income racial and ethnic minority patients.
Although the overall rate of admissions to substance abuse treatment in the U.S. remained stable between 1998 and 2008, at about 770 admissions for every 100,000 persons in the population, a new study shows striking changes and variations in admission rates by region. For example, the rate of admissions for alcohol as the primary drug has declined by 15 percent nationally. However admission rates for alcohol in West North Central states (Ark., Iowa, Kan., Minn., Mo., N.D., Neb. and S.D.) remained the same.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.
A recent study discusses the findings of a study on patients with hematologic cancers who received convalescent plasma therapy following their diagnosis of COVID-19.
Current efforts to prevent prescription drug misuse among young adults need to consider peers - but not peer pressure - according to a Purdue University study.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Katrivesis, MD 190 E Bannock St, Boise, ID 83712-6241 Ph: () - | James Katrivesis, MD 3277 E Louise Dr Ste 100, Meridian, ID 83642-9360 Ph: (208) 706-7086 |
News Archive
Researchers from the University of Chicago Medicine have received a five-year, $1.8 million grant, from the U.S. Department of Health and Human Services Office of Minority Health to develop a program that could help improve diabetes care for low-income racial and ethnic minority patients.
Although the overall rate of admissions to substance abuse treatment in the U.S. remained stable between 1998 and 2008, at about 770 admissions for every 100,000 persons in the population, a new study shows striking changes and variations in admission rates by region. For example, the rate of admissions for alcohol as the primary drug has declined by 15 percent nationally. However admission rates for alcohol in West North Central states (Ark., Iowa, Kan., Minn., Mo., N.D., Neb. and S.D.) remained the same.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.
A recent study discusses the findings of a study on patients with hematologic cancers who received convalescent plasma therapy following their diagnosis of COVID-19.
Current efforts to prevent prescription drug misuse among young adults need to consider peers - but not peer pressure - according to a Purdue University study.
› Verified 9 days ago